Quoting dday1: Current BTA had nothing to do with Relenza licencing. In the industry 7%-10% is not a bad deal anywway for his type of thing.
For a minute I almost believe it. Then I remembered the guy had put every spare $ into Biota and is suffering a paper loss - therefore trying to ramp up the shares or perhaps posting as a stooge for management.
The current management refused the $100m settlement offer and the sold out shareholders for $20m purportedly to normalised relationship. Who is that a broken record player that keep posting the current BTA management has nothing to do with the licensing. LOL
BTA Price at posting:
$1.13 Sentiment: Sell Disclosure: Not Held